FDA
- Status: approved
Dexamethasone Cyclophosphamide Pulse therapy (Dexamethasone Cyclophosphamide Pulse therapy) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Jinnah Postgraduate Medical Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.